AFFAMED THERAPEUTICS

affamed-therapeutics-logo

AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.

#SimilarOrganizations #People #Financial #More

AFFAMED THERAPEUTICS

Social Links:

Industry:
Biotechnology

Founded:
2019-01-01

Address:
New City, New York, United States

Country:
United States

Total Employee:
101+

Status:
Active

Total Funding:
170 M USD


Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Employees Featured

not_available_image

Vijay Karwal
Vijay Karwal Chief Financial Officer @ AffaMed Therapeutics
Chief Financial Officer

michael-keyoung_image

Michael Keyoung
Michael Keyoung Chairman of the Board @ AffaMed Therapeutics
Chairman of the Board
2019-01-01

ji-li_image

Ji Li
Ji Li President @ AffaMed Therapeutics
President
2021-01-01

not_available_image

Dayao Zhao
Dayao Zhao Chief Executive Officer & Board Member @ AffaMed Therapeutics
Chief Executive Officer & Board Member

Acquisitions List

Date Company Article Price
2020-10-14 EverInsight Therapeutics EverInsight Therapeutics acquired by AffaMed Therapeutics N/A

Investors List

orion-capital-group-inc_image

Orion Capital Group, Inc.

Orion Capital Group, Inc. investment in Series B - AffaMed Therapeutics

cbc-investment-group_image

CBC Investment Group

CBC Investment Group investment in Series B - AffaMed Therapeutics

fountainhead-investment-partners_image

Fountainhead Investment Partners

Fountainhead Investment Partners investment in Series B - AffaMed Therapeutics

lake-bleu-capital_image

Lake Bleu Capital

Lake Bleu Capital investment in Series B - AffaMed Therapeutics

partners-investment_image

Partners Investment

Partners Investment investment in Series B - AffaMed Therapeutics

superstring-capital_image

Superstring Capital

Superstring Capital investment in Series B - AffaMed Therapeutics

More informations about "AffaMed Therapeutics"

AffaMed Therapeutics - Crunchbase Company Profile & Funding

AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products. New City , New York , United States โ€ฆSee details»

AffaMed Therapeutics Company Profile 2024: โ€ฆ

AffaMed Therapeuticsโ€™s most recent deal was a Joint Venture with AffaMed Therapeutics & SIFI (Joint Venture) for . The deal was made on 31-Mar-2021. The deal was made on 31-Mar-2021. Company NameSee details»

AffaMed Therapeutics - Org Chart, Teams, Culture & Jobs - The Org

AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address โ€ฆSee details»

AffaMed Therapeutics Company Profile | Management and

AffaMed Therapeutics Profile and History. AffaMed Therapeutics is a clinical stage biopharmaceutical company focused on developing and commercializing transformative โ€ฆSee details»

Leadership-AffaMed่”ผ็ฆๅŒป็–—

ๆฒช ICP ๅค‡ 2021003460-1 ©2021 AffaMed Therapeutics ๏ผš31010602006246 ... Ms. Jiang served as Director and COO at Far East Horizonโ€™s Investments Group, a financial services โ€ฆSee details»

AffaMed Therapeutics - LinkedIn

AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address โ€ฆSee details»

AskGene Pharma, Inc. - Drug pipelines, Patents, Clinical trials

SHANGHAI, May 30, 2022 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing โ€ฆSee details»

AffaMed Therapeutics - Overview, News & Similar companies

Oct 31, 2023 AffaMed Therapeutics is a clinical stage biopharmaceutical company focused on developing and commercializing transformative pharmaceutical, digital and surgical products โ€ฆSee details»

Our Mission & Vision-AffaMed่”ผ็ฆๅŒป็–—

AffaMed Therapeutics is a late clinical-stage biopharmaceutical company focused on developing and commercializing transformative medical devices and pharmaceutical products โ€ฆSee details»

AffaMed Therapeutics - Funding, Financials, Valuation & Investors

AffaMed Therapeutics is funded by 6 investors. C-Bridge Capital and Orion Capital Group, Inc. are the most recent investors. AffaMed Therapeutics has acquired EverInsight Therapeutics โ€ฆSee details»

AffaMed Therapeutics - Contacts, Employees, Board Members

AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products. Search Crunchbase Start Free TrialSee details»

AffaMed Therapeutics Announces Merger with EverInsight โ€ฆ

Oct 14, 2020 AffaMed Therapeutics was founded and funded by the CBC Group in 2019.About EverInsight TherapeuticsEverInsight Therapeutics is a biopharmaceutical company focused on โ€ฆSee details»

AskGene Pharma Announces First Development Milestone in โ€ฆ

Camarillo, California, June 20, 2022 โ€“ AskGene Pharma Inc., an innovative clinical-stage biotech company, announces that its partner AffaMed has dosed the first patient in its US Phase 1 โ€ฆSee details»

AffaMed Therapeutics Announces the Establishment of AffaMed โ€ฆ

SHANGHAI, Nov. 10, 2021 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical-stage therapeutic company dedicated to developing and commercializing transformative โ€ฆSee details»

VistaGen and AffaMed Complete Key Regulatory Submissions for โ€ฆ

Apr 13, 2022 VistaGen Therapeutics, Inc. (Nasdaq: VTGN) (VistaGen) and AffaMed Therapeutics (AffaMed) today announced they have completed regulatory preparations to โ€ฆSee details»

AffaMed Therapeutics Announces New Drug Application โ€ฆ

Feb 19, 2024 AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative pharmaceutical, and surgical products that โ€ฆSee details»

Series B - AffaMed Therapeutics - 2021-03-30 - Crunchbase

Mar 30, 2021 Organization Name . AffaMed Therapeutics . Announced Date Mar 30, 2021; Funding Type Series B; Funding Stage Early Stage Venture; Money Raised . obfuscated. โ€ฆSee details»

AffaMed Therapeutics Announces Completion of over US$170 โ€ฆ

Mar 30, 2021 AffaMed Therapeutics was founded and funded by the CBC Group in 2019. About Lake Bleu Capital Based in Hong Kong and Shanghai , Lake Bleu Capital ( www.lakebleu โ€ฆSee details»

Working at AffaMed Therapeutics - Glassdoor

Glassdoor gives you an inside look at what it's like to work at AffaMed Therapeutics, including salaries, reviews, office photos, and more. This is the AffaMed Therapeutics company profile. โ€ฆSee details»

linkstock.net © 2022. All rights reserved